Overlap of these RNA-based predictions with chromatin-based CRC MRs (Fig. 3d) gave a consensus list of 10 MRs (Fig. 5a), from which we selected SOX10 for functional validation. This evidence concerns the gene SOX10 and colorectal carcinoma.